Protecting Newborn Brains Via Innovative Monitoring Technology
Funder
National Health and Medical Research Council
Funding Amount
$394,460.00
Summary
This project aims to develop innovative brain monitoring technology which could help minimise brain damage in newborn babies with brain injuries, thereby delivering a healthier start to life. Such novel technology may automatically analyse babies’ brain activity and deliver instant detection of critical abnormalities, which could enable more effective treatment of brain injuries. Babies with reduced oxygen or blood supply to the brain and premature babies could benefit from such innovations.
The Cellular And Molecular Mechanisms In The Initaition Of Human Labour
Funder
National Health and Medical Research Council
Funding Amount
$460,904.00
Summary
Being born too early is the major cause of perinatal morbidity and mortality and accounts for the majority of neonatal deaths. The aim of this project is to gain a better understanding of the mechanisms involved in premature birth with a view to future development of clinically useful interventions to reduce the high rates of mortality and long-term disability.
Improving And Evaluating The Health Of Mothers And Babies
Funder
National Health and Medical Research Council
Funding Amount
$320,848.00
Summary
This research program considers new ways to monitor an unborn baby’s health and to provide better care for childbearing women. Several projects will test the unborn baby’s well being. A new study will consider two forms of cooling treatments to help relieve pain following childbirth. Further research involves studies of the genetics of increased blood pressure in pregnant women and a structured way of looking at existing evidence to consider how well it delivers.
The Early Origins Of Obsteric Diseases: Biological Investigations And Biomarker Discovery
Funder
National Health and Medical Research Council
Funding Amount
$282,290.00
Summary
Recent evidence has pointed to the beginning of pregnancy as the time when biological cascades begin that cause common diseases of pregnancy. This opens the door to developing bloods test in early pregnancy predicting who will develop problems, and to hunt for novel proteins in the bloodstream that are causing the illnesses. 'Proteomic technology' will be used, a new cutting edge tool that can scan the entire protein pool in mum's blood in a single experiment.